Dietary fibre and IBD risk (Nurses’ Health Study cohort-US)
Mesalazine in UC, one or two doses/day
Certolizumab in CD
Safety and Tolerability of Low-dose Naltrexone Therapy in Children With Moderate to Severe Crohn’s Disease A Pilot Study